KRM Ayurveda

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE1MTV01019
  • NSEID: KRMAYURVED
  • BSEID:
INR
254.75
-9.6 (-3.63%)
BSENSE

May 06

BSE+NSE Vol: 369000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Mar'26
Sep'25
Mar'25
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Mar 2026 is 10.28% vs 18.41% in Sep 2025

stock-summary

Standalone Net Profit

Growth in half year ended Mar 2026 is 46.19% vs 70.29% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Mar 2026 is 36.60% vs 51.95% in Sep 2025

stock-summary

Interest

Growth in half year ended Mar 2026 is -3.14% vs -11.67% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Mar 2026 has improved from Sep 2025

Compare Half Yearly Results Of KRM Ayurveda With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
53.33
0.00
53.33
Other Operating Income
0.00
0.00
0.00
Total Operating income
53.33
0.00
53.33
Raw Material Cost
6.17
0.00
6.17
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
11.03
0.27
10.76
3,985.19%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
18.59
2.04
16.55
811.27%
Total Expenditure (Excl Depreciation)
35.79
2.31
33.48
1,449.35%
Operating Profit (PBDIT) excl Other Income
17.54
-2.31
19.85
859.31%
Other Income
0.33
-0.03
0.36
1,200.00%
Operating Profit (PBDIT)
17.87
-2.34
20.21
863.68%
Interest
1.54
0.29
1.25
431.03%
Exceptional Items
0.00
0.01
-0.01
-100.00%
Gross Profit (PBDT)
16.33
-2.63
18.96
720.91%
Depreciation
0.61
0.00
0.61
Profit Before Tax
15.72
-2.63
18.35
697.72%
Tax
3.83
0.16
3.67
2,293.75%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
11.90
-2.79
14.69
526.52%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.01
-0.01
-100.00%
Net Profit
11.90
-2.78
14.68
528.06%
Equity Capital
21.26
14.79
6.47
43.75%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.60
-0.19
5.79
3,047.37%
Diluted Earnings per share
5.60
-0.19
5.79
3,047.37%
Operating Profit Margin (Excl OI)
32.89%
0.00%
0.00
32.89%
Gross Profit Margin
30.62%
0.00%
0.00
30.62%
PAT Margin
22.31%
0.00%
0.00
22.31%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 53.33 Cr
in Mar 2026

Figures in Cr
stock-summary

Growth in half year ended Mar 2026 is 10.28% vs 18.41% in Sep 2025

Half Yearly - Standalone Net Profit
Standalone Net Profit 11.90 Cr
in Mar 2026

Figures in Cr
stock-summary

Growth in half year ended Mar 2026 is 46.19% vs 70.29% in Sep 2025

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.54 Cr
in Mar 2026

Figures in Cr
stock-summary

Growth in half year ended Mar 2026 is 36.60% vs 51.95% in Sep 2025

Half Yearly - Interest
Interest 1.54 Cr
in Mar 2026

Figures in Cr
stock-summary

Growth in half year ended Mar 2026 is -3.14% vs -11.67% in Sep 2025

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.89%
in Mar 2026

Figures in %
stock-summary

Growth in half year ended Mar 2026 has improved from Sep 2025